Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Submission of a Prior Approval Supplement for a reduction in the number of patients in the NEPHRO CRRT study is expected within the coming week

The FDA agreed to two additional protocol changes expected to accelerate enrollment in the NEPHRO CRRT study

Read more at prnewswire.com